Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial.
Goebeler M, Bata-Csörgő Z, De Simone C, Didona B, Remenyik E, Reznichenko N, Stoevesandt J, Ward ES, Parys W, de Haard H, Dupuy P, Verheesen P, Schmidt E, Joly P; ARGX-113-1701 Investigator Study Group. Goebeler M, et al. Among authors: bata csorgo z. Br J Dermatol. 2022 Mar;186(3):429-439. doi: 10.1111/bjd.20782. Epub 2021 Nov 28. Br J Dermatol. 2022. PMID: 34608631 Clinical Trial.
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations.
Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H, De Jong E, Garcia-Doval I, Gisondi P, Kaur-Knudsen D, Mahil S, Mälkönen T, Maul JT, Mburu S, Mrowietz U, Reich K, Remenyik E, Rønholt KM, Sator PG, Schmitt-Egenolf M, Sikora M, Strömer K, Sundnes O, Trigos D, Van Der Kraaij G, Yawalkar N, Dressler C. Nast A, et al. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):281-317. doi: 10.1111/jdv.16926. J Eur Acad Dermatol Venereol. 2021. PMID: 33547728 Free article.
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations.
Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H, De Jong E, Garcia-Doval I, Gisondi P, Kaur-Knudsen D, Mahil S, Mälkönen T, Maul JT, Mburu S, Mrowietz U, Reich K, Remenyik E, Rønholt KM, Sator PG, Schmitt-Egenolf M, Sikora M, Strömer K, Sundnes O, Trigos D, Van Der Kraaij G, Yawalkar N, Dressler C. Nast A, et al. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2461-2498. doi: 10.1111/jdv.16915. J Eur Acad Dermatol Venereol. 2020. PMID: 33349983
Dermatology Life Quality Index (DLQI) score bands are applicable to DLQI-Relevant (DLQI-R) scoring.
Rencz F, Gergely LH, Wikonkál N, Gáspár K, Péntek M, Gulácsi L, Tamási B, Poór AK, Kinyó Á, Bali G, Hidvégi B, Sárdy M, Hajdu K, Szegedi A, Remenyik É, Bata-Csörgő Z, Holló P, Baji P, Brodszky V. Rencz F, et al. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e484-e486. doi: 10.1111/jdv.16398. Epub 2020 May 12. J Eur Acad Dermatol Venereol. 2020. PMID: 32243628 No abstract available.
A simple, combined test can improve the diagnosis of autoimmune urticaria.
Hajdu K, Irinyi B, Gyimesi E, Kapitány A, Dajnoki Z, Bata-Csörgő Z, Kinyó Á, Kiss F, Gáspár K, Szegedi A. Hajdu K, et al. Br J Dermatol. 2017 Sep;177(3):864-866. doi: 10.1111/bjd.15175. Epub 2017 Jun 28. Br J Dermatol. 2017. PMID: 27858998 No abstract available.
103 results